Zura Bio Ltd
ZURA · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Mathew Marlyn Teresa: Form 3
Insider disclosure · Filed · Report period 17 Apr 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ZURA · G9TY5A101 - Class A Ordinary Shares, par value $0.0001 per share
Company details and SEC sources
CIK 0001855644 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ZURA on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 4225 Executive Square, Suite 600, La Jolla, CA, 92037
- Incorporated in
- Cayman Islands
- Fiscal year end
- 31 December
- Former names on EDGAR
- JATT Acquisition Corp (to 21 Mar 2023)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields